Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Two Dose Levels of Albiglutide Compared With Placebo in Subjects With Type 2 Diabetes Mellitus
albiglutide
GLP112756
NCT00849017
Diabetes Mellitus, Type 2
Phase 3
 
This study is available in CDISC format
March 2016

Powered by ideaPoint, Inc.